Optimal Tolerogenic Dendritic Cells in Type 1 Diabetes (T1D) Therapy: What Can We Learn From Non-obese Diabetic (NOD) Mouse Models?

David P. Funda(Czech Academy of Sciences), Radek Špíšek(Charles University)

Frontiers in Immunology

May 14, 2019

10.3389/fimmu.2019.00967

Cited by 14

Related Papers

No related papers found

Powered by citation graph analysis